The markets closed higher with the Dow gaining 46 points to 23,979 after officials indicated that negotiations with China would likely ease proposed tariffs. Nasdaq climbed 35 points to 6950.
On the upside
Turtle Beach (Nasdaq: HEAR) reported preliminary first quarter earnings and revenue ahead of previous guidance.
Chardan Capital lifted its price target on Regenxbio (Nasdaq: RGNX) from $85.00 to $90.00.
Intelsat (NYSE: I) introduced a new Ku-bnd Multi-Channel Per Carrier media platform for Central and Eastern Europe.
On the downside
Menlo Therapeutics (Nasdaq: MNLO) reported disappointing results from a Phase 2 clinical trial of serlopitant to treat pruritus in adults and adolescents with a history of atopic dermatitis.
Essent Group (NYSE: ESNT), NMI Holdings (Nasdaq: NMIH) and Radian Group (NYSE: RDN) may all be forced to slash their premiums after rival MGIC Investment (NYSE: MTG) announced premium cuts.
Veon Group (Nasdaq: VEON) will sell its Takom subsidiary.
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by nearly 6 to 5 on Nasdaq. The broader S&P 500 rose 8 points to 2,613. Bitcoin crashed $340 to $6,659.